Navigation Links
Therapeutic Area Essentials "Class of 2011" Brings Current Disease State Training to Pharma
Date:6/20/2011

RALEIGH, N.C., June 20, 2011 /PRNewswire/ -- Pharmaceutical Institute, the leading provider of specialized training solutions for the pharmaceutical and biotech industry and a subsidiary of Campbell Alliance, announced today the completion of 2011 updates to its Therapeutic Area Essentials™ e-course series.  This series delivers in-depth disease state training for pharmaceutical and biotech R&D and commercial professionals.  It includes 155 e-courses covering the diagnosis, cause, and treatment for more than 45 disease states.

Therapeutic Area Essentials™ provides the pharmaceutical and biotech industry with a single source for current and comprehensive disease state training.  All courses have been updated in 2011 by Pharmaceutical Institute's content scientists and physician experts.  Updates reflect the most current disease state knowledge such as prevalence and incidence statistics, disease understanding (including cause, risk factors, and progression), diagnostic procedures, and treatment guidelines.  

"Providing pharma and biotech employees with immediate, needs-based access to high quality disease state training can deliver significant value," says Garry O'Grady, Senior Vice President and General Manager of Pharmaceutical Institute.  "We're pleased to provide a go-to resource for high-quality training content across the therapeutic area spectrum."

Core therapeutic areas covered by Therapeutic Area Essentials™ include cardiology and metabolic disorders, gastroenterology, infections, musculoskeletal, neurology, oncology, ophthalmology, and respiratory disorders.  The series also provides anatomy and physiology training for each of these systems.

For more information on the Therapeutic Area Essentials™ training solutions, including a complete list of courses, please visit: http://www.pharmainstitute.com/elearning/therapeutic-area-essentials/.

About Pharmaceutical Institute

Pharmaceutical Institute is the leading provider of specialized training programs for the pharmaceutical and biotech industry.  We partner with subject matter experts from our parent company, Campbell Alliance, to develop high-impact distance learning solutions for professionals within all major pharmaceutical company functions including brand management, business development, clinical development, managed markets, medical affairs, sales, and trade and distribution.  Pharmaceutical Institute is based in Raleigh, N.C.  For more information, please visit www.pharmainstitute.com.


'/>"/>
SOURCE Pharmaceutical Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Alder Biopharmaceuticals to Receive $15 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2b Clinical Trial in Rheumatoid Arthritis of ALD518/BMS-945429 Antibody Therapeutic Against IL-6
2. Cell Therapeutics, Inc. Reports Outcome of Special Meeting of Shareholders
3. Pearl Therapeutics Advances Its Long-Acting Bronchodilator Combination Product Candidate into Four Additional Phase 2 Studies
4. Sanofi Enters Into Research Collaboration With Biopharmaceutical Company Audion Therapeutics to Develop Potential Treatments for Hearing Loss
5. Cardinal Health, Prime Therapeutics Renew Primary Distribution Agreement
6. Sangart Initiates Phase 2b Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
7. Cell Therapeutics Completes Type A Meeting With FDAs Division of Oncology Drug Products: Guidance Provided for Resubmission of Pixantrone NDA for Consideration of Accelerated Approval
8. Enox Biopharma, Inc. Will Be Granted a Patent for the Delivery of Therapeutic Agents From Within Medical Devices
9. Novelos Therapeutics to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16
10. Grifols Announces Combined Operations With Talecris to Begin a New Era as a Global Leader of Life-Saving Plasma Therapeutics
11. Healthpoint Biotherapeutics to Present at Upcoming Investment Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016 Australia Glaucoma ... GlobalData,s new report, "Australia Glaucoma Surgery Devices ... on the Australia Glaucoma Surgery Devices market. The ... volume (in units) and average prices (USD) within ... report also provides company shares and distribution shares ...
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... poised to grow in 2017-2023. Various reasons for growth ... obese population, higher incidences of chronic diseases, high recovery ... mobility aid services. Medical lifting sling refers to ... with limited mobility. These slings connect to the lift ...
(Date:12/8/2016)... INDIANAPOLIS , Dec. 8, 2016  Eli Lilly ... detailed results of its phase 3 EXPEDITION3 trial at ... (CTAD) meeting. As previously disclosed, solanezumab did not meet ... study of solanezumab initiated in people with mild dementia ... pursue regulatory submissions for solanezumab for the treatment of ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) aired ... of 2016. The program was made possible by a Pennsylvania Department of Health ... and Human Services Administration. The broadcast, Use Your Head: Properly Managing Sport ...
(Date:12/8/2016)... Islandia, NY (PRWEB) , ... December 08, 2016 ... ... company, is pleased to announce that “Natural Language Processing–Enabled and Conventional Data Capture ... published in JMIR Medical Informatics . , Results of the comparative usability ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick ... West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is ... Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Center has been recognized for adherence to the highest standards of trauma, ... accreditation organizations, announced the center's president and CEO, Dr. Daniel Messina. , Among ...
(Date:12/8/2016)... ... 2016 , ... Vida Health, the digital health platform that pairs ... Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and returning investor Aspect ... consumers who are managing chronic conditions or simply want to improve their ...
Breaking Medicine News(10 mins):